Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) partner GSK today announced positive results from two pivotal Phase 3 studies, ...
But a team of Chinese researchers has managed to turn sulfur’s complex chemistry into a strength, making it the primary ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback